Georgia Department of Corrections. (January 2, 2026). Profile of inmates admitted during CY2025 for methamphetamine. Georgia Department of Corrections.
South Carolina Department of Alcohol and Other Drug Abuse Services. (Unknown). 2026 AC HIDTA Threat Assessment. South Carolina Department of Alcohol and Other Drug Abuse Services.
Georgia Department of Behavioral Health and Developmental Disabilities. (September 1, 2025). The 2025 Georgia Social Indicator Study—Overall. Georgia Department of Behavioral Health and Developmental Disabilities.
Georgia Department of Public Health. (February 18, 2026). Drug Surveillance. Georgia Department of Public Health.
Centers for Disease Control and Prevention. (March 3, 2026). Vital Statistics Rapid Release – Provisional Drug Overdose Data. Centers for Disease Control and Prevention.
Drug Enforcement Administration. (Unknown). 2025 National Drug Threat Assessment. Drug Enforcement Administration.
Vanderbilt University School of Nursing. (November 15, 2012). How Meth Impacts Brain Chemistry. Vanderbilt University School of Nursing.
National Center for Biotechnology Information. (June 11, 2023). The Neurobiology of Methamphetamine Addiction and the Potential. National Center for Biotechnology Information.
Center for Substance Abuse Research, University of Maryland. (Unknown). Methamphetamine Highlights. Center for Substance Abuse Research, University of Maryland.
City of Clarkston, GA. (April 1, 2025). Methamphetamine. City of Clarkston, GA.
National Institute of Justice. (Unknown). Methamphetamine and Other Substance Use Trends among Street. National Institute of Justice.
National Criminal Justice Reference Service. (Unknown). MIDl~®. National Criminal Justice Reference Service.
U.S. Department of Justice. (Unknown). Georgia Drug Threat Assessment. U.S. Department of Justice.
Office of Justice Programs. (Unknown). Methamphetamine Use Among Adult Arrestees. Office of Justice Programs.
National Center for Biotechnology Information. (September 15, 2022). Methamphetamine Use: A Narrative Review of Adverse Effects and. National Center for Biotechnology Information.
National Center for Biotechnology Information. (June 24, 2011). Neurologic manifestations of chronic methamphetamine abuse. National Center for Biotechnology Information.
Centers for Disease Control and Prevention. (March 27, 2020). Patterns and Characteristics of Methamphetamine Use Among Adults. Centers for Disease Control and Prevention.
National Center for Biotechnology Information. (Unknown). Methamphetamine-associated heart failure: Clinical characteristics. National Center for Biotechnology Information.
National Center for Biotechnology Information. (April 11, 2013). Neurologic Manifestations of Chronic Methamphetamine Abuse. National Center for Biotechnology Information.
National Center for Biotechnology Information. (February 25, 2024). Treatment Disparities in Georgia: Methamphetamine Use Disorder. National Center for Biotechnology Information.
JAMA Network. (September 22, 2021). Methamphetamine Use, Use Disorder, and Overdose Deaths. JAMA Network.
Centers for Disease Control and Prevention. (March 27, 2020). Patterns and Characteristics of Methamphetamine Use Among Adults. Centers for Disease Control and Prevention.
Substance Abuse and Mental Health Services Administration. (April 30, 2011). Psychiatric comorbidity in methamphetamine dependence. Substance Abuse and Mental Health Services Administration.
National Center for Biotechnology Information. (Unknown). Methamphetamine Psychosis: Epidemiology and Management. National Center for Biotechnology Information.
National Center for Biotechnology Information. (August 6, 2018). Methamphetamine psychosis: insights from the past. National Center for Biotechnology Information.
National Institutes of Health. (Unknown). Methamphetamine. National Institutes of Health.
National Center for Biotechnology Information. (December 13, 2021). Current and Emerging Treatments for Methamphetamine Use Disorder. National Center for Biotechnology Information.
National Center for Biotechnology Information. (November 10, 2025). Efficacy of cognitive behavioral therapy for stimulant use disorders. National Center for Biotechnology Information.
National Center for Biotechnology Information. (Unknown). A systematic review of cognitive and/or behavioural therapies. National Center for Biotechnology Information.
Substance Abuse and Mental Health Services Administration. (June 9, 2023). National Helpline for Mental Health, Drug, Alcohol Issues. Substance Abuse and Mental Health Services Administration.
U.S. Food and Drug Administration. (Unknown). Desoxyn (methamphetamine hydrochloride tablets, USP) Rx only. U.S. Food and Drug Administration.
U.S. Food and Drug Administration. (October 4, 2023). FDA Takes Steps to Advance the Development of Novel Therapies. U.S. Food and Drug Administration.
Department of Veterans Affairs. (Unknown). Army Veteran declares victory on a 50-year battle. Department of Veterans Affairs.